https://orcid.org/0000-0003-3232-7713
Figures & data
Table 1. Distribution of clinical characteristics and scale scores of the patients participating in the study.
Table 2. Comparison of baseline and final scores in patients completing the study.
Figure 1. Change in BPRS scores over time.
Figure 2. Change in SANS scores over time.
Figure 3. Change in SAPS scores over time.
Figure 4. Change in GAF scores over time.
Figure 5. Change in plasma haloperidol levels over time.
Table 3. The Relationship between haloperidol dose and SAS side effect scale scores of patients completing the study.
Figure 6. Changes in SAS scale scores over time.
Figure 7. Changes in prolactin levels over time.
Table 4. Comparison of changes in metabolic measurements of patients completing the study over time.
Table 5. Comparison of weight and waist circumference measurements of follow-up patients RepeatedMeasures MANOVA.
Figure 8. Percentage of reasons why patients discontinued haloperidol decanoate treatment.
